City

Kunming (3)

Condition

B Cell Lymphoma (3)

B-Cell Leukemia (1)

B-cell Acute Lymphoblastic Leukemia (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1)

Chongqing Precision Biotech Co., Ltd (1)

Yan'an Affiliated Hospital of Kunming Medical University (1)

Collaborator

Gracell Biotechnology Shanghai Co., Ltd. (1)

Intervention

anti-cd19 car-t cells injection (1)

anti-cd19 ucar-t injection (1)

cd19 and cd22 targeted prime car- t cells (1)

Study Documents

Intervention Type

biological (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

b cell lymphoma

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)

Recruiting

B-Cell Leukemia
B Cell Lymphoma

anti-CD19 UCAR-T injection

Kunming, Yunnan, China

920th Hospital of Joint Logistics Support Force of People's Libe

Apr 21, 2022

B Cell Lymphoma Trial in Kunming (CD19 and CD22 targeted prime CAR- T cells)

Recruiting

B Cell Lymphoma

CD19 and CD22 targeted prime CAR- T cells

Kunming, Yunnnan, China

920th Hospital of Joint Logistics Support Force

Jul 30, 2021

B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Kunming (Anti-CD19 CAR-T Cells Injection)

Recruiting

B Cell Lymphoma
B-cell Acute Lymphoblastic Leukemia

Anti-CD19 CAR-T Cells Injection

Kunming, Yunnan, China

Kunming Yan'an Hospital

May 12, 2021